spacer
home > pmps > spring 2017 > breathing new life into asthma care
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing New Life into Asthma Care

Smart inhalers represent a convergence of several market forces, technology and trends that are poised to change asthma care and improve outcomes. They are part of an overall smart device trend in mHealth focused at the multibillion dollar asthma industry. One of the biggest culprits of poor patient outcomes in asthma care is taking a reactive rather than proactive approach to treatment, and poor adherence of care plans among patients.

Why Smart Inhalers?

The technology around these devices can offer a number of benefits to both the patient and the healthcare provider, such as making it easier to remember to take prevention medicine and report symptoms, which can lead to improved disease self-management and adherence rates. Other benefits include their ability to collect actionable data and patients being able to identify their own patterns. Sixty-seven percent of patients do not take their inhalers correctly. With smart sensors built into these devices, the patient is told if they have shaken it correctly or not.

The sensors can also detect the quality of inhalation, which is very important when it comes to judging the effectiveness of the medication. Collection of key data, recognising patterns and potential aggravators to severe asthma attacks can help reduce costly readmissions and result in improved disease management as well as adherence rates. In the future, a convergence of trends and technologies will put smart inhalers and their accompanying data at the epicentre of managing asthma care. To this end, some companies

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
An engineer at heart and entrepreneur by trade, Ali Moiyed is founder and Chief Executive Officer of Aerobit Health. Living with asthma himself, he launched the digital healthcare company in July 2016.
spacer
Ali Moiyed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Horizon Discovery Licenses Biomanufacturing Cell Lines to Centre for Process Innovation (CPI) and National Institute for Bioprocessing Research and Training (NIBRT)


More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

Partnerships in Clinical Trials Europe 2017

28-29 November 2017, RAI, Amsterdam

PCT Europe is back, bringing you the latest information from across the clinical trials spectrum and providing you with direct access to the industry's leading innovators. And this year, we're in Amsterdam!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement